Pseudoerythromycin A enol ether

Pseudoerythromycin A enol ether

• CAS Number: 105882-69-7
• UNSPSC Description: Pseudoerythromycin A enol ether (LY267108) is a degradation product of Erythromycin. Pseudoerythromycin A enol ether has no significant antimicrobial activity[1][2].
• Target Antigen: Drug Metabolite
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Metabolism-protein/nucleotide metabolism
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/pseudoerythromycin-a-enol-ether.html
• Solubility: 10 mM in DMSO
• Smiles: C[C@@](OC([C@@H]([C@]1([H])[C@](C)(O)[C@H](O)CC)C)=C2C)(C2)[C@@H]([C@H]([C@@H]([C@H](C(O1)=O)C)O[C@H](O[C@H]3C)C[C@](C)([C@H]3O)OC)C)O[C@H](O[C@@H]4C)[C@@H]([C@H](C4)N(C)C)O
• Molecular Weight: 715.91
• References & Citations: [1]Pendela M, et al. Combined use of liquid chromatography with mass spectrometry and nuclear magnetic resonance for the identification of degradation compounds in an erythromycin formulation. Anal Bioanal Chem. 2012;402(2):781-790.|[2]Greenwood B, et al. Effects of LY267108, an erythromycin analogue derivative, on lower esophageal sphincter function in the cat. Gastroenterology. 1994;106(3):624-628.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported